(Q46087968)

English

Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction

scientific article published on 13 March 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

myocardial infarction

1 reference

based on heuristic

inferred from title

author name string

Shinji Yasuda

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

Hiroyuki Kobayashi

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

Masamitsu Iwasa

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

Itta Kawamura

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

Shouhei Sumi

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

Bao Narentuoya

6

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

Takahiko Yamaki

7

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

Hiroaki Ushikoshi

8

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

Kazuhiko Nishigaki

9

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

Kenshi Nagashima

10

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

Genzou Takemura

11

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

Takako Fujiwara

12

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

Hisayoshi Fujiwara

13

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

Shinya Minatoguchi

14

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

publication date

13 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

American Journal of Physiology Heart and Circulatory Physiology

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

296

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

H1558-65

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

Pravastatin reduces myocardial infarct size via increasing protein kinase C-dependent nitric oxide, decreasing oxyradicals and opening the mitochondrial adenosine triphosphate-sensitive potassium channels in rabbits

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00712.2008

21 January 2018

Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00712.2008

21 January 2018

Quinaprilat reduces myocardial infarct size involving nitric oxide production and mitochondrial KATP channel in rabbits

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00712.2008

21 January 2018

Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00712.2008

21 January 2018

Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00712.2008

21 January 2018

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00712.2008

21 January 2018

Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00712.2008

21 January 2018

Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia/reperfusion injury in a rat model

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00712.2008

21 January 2018

Diabetes and cardiovascular disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00712.2008

21 January 2018

ROS and NO trigger early preconditioning: relationship to mitochondrial KATP channel

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00712.2008

21 January 2018

Effect of myocardial oxygen consumption on infarct size in experimental coronary artery occlusion

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00712.2008

21 January 2018

The role of serotonin in ischemic cellular damage and the infarct size-reducing effect of sarpogrelate, a 5-hydroxytryptamine-2 receptor blocker, in rabbit hearts

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00712.2008

21 January 2018

Sheng-Mai-San is protective against post-ischemic myocardial dysfunction in rats through its opening of the mitochondrial KATP channels

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00712.2008

21 January 2018

Benidipine reduces myocardial infarct size involving reduction of hydroxyl radicals and production of protein kinase C-dependent nitric oxide in rabbits

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00712.2008

21 January 2018

Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00712.2008

21 January 2018

Pioglitazone mimics preconditioning in the isolated perfused rat heart: a role for the prosurvival kinases PI3K and P42/44MAPK.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00712.2008

21 January 2018

Thiazolidinediones

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00712.2008

21 January 2018

Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00712.2008

21 January 2018

Identifiers

10.1152/AJPHEART.00712.2008

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19286954

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46087968&oldid=2091497340"